zm 241385 has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonaventura, J; Brugarolas, M; Casadó, V; Cellai, L; Chang, CP; Chern, Y; Cortés, A; Dettori, I; Ferré, S; Guitart, X; Narayanan, M; Orrú, M; Pedata, F; Rea, W | 1 |
| Abbracchio, MP; Bates, G; Borea, PA; Camurri, A; Cattaneo, E; Tarditi, A; Varani, K; Woodman, B | 1 |
2 other study(ies) available for zm 241385 and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Biomarkers; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Humans; Huntingtin Protein; Huntington Disease; Locomotion; Nucleoside Transport Proteins; Prefrontal Cortex; Psychomotor Disorders; Purines; Rats; Rats, Transgenic; Receptor, Adenosine A2A; Triazines; Triazoles; Trinucleotide Repeat Expansion; Tritium | 2016 |
Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease.
Topics: Adenylyl Cyclases; Animals; Basal Ganglia; Cyclic AMP; Disease Models, Animal; Huntington Disease; Mice; Mice, Transgenic; Receptors, Adenosine A2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Triazines; Triazoles | 2006 |